Melanoma BRAF V600E/K Mutated
4 clinical trials · Condition
◉ Watch Melanoma BRAF V600E/K Mutated
| Record | Firm | Date |
|---|---|---|
| Phase I-II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation and Pharmacokinetics of PD-0332991 in Patients Suffering Metastatic Melanoma (NCT02202200) | Assistance Publique - Hôpitaux de Paris | 2014-05-01 |
Track Melanoma BRAF V600E/K Mutated automatically
Every clearance here is in the API, with alerts when new ones post.